Enzyme may be key to cancer progression in many tumors
Wednesday, November 26, 2014 - 15:30
in Health & Medicine
A deeper understanding of how KRAS turns off tumor suppressor genes and identifies a key enzyme in the process has been gained by researchers. The findings suggest that this enzyme, known as TET1, may be an important target for cancer diagnostics and treatment.